EP4568560A1 - Health event prediction using heartbeat intervals from electrocardiogram data - Google Patents
Health event prediction using heartbeat intervals from electrocardiogram dataInfo
- Publication number
- EP4568560A1 EP4568560A1 EP23754907.6A EP23754907A EP4568560A1 EP 4568560 A1 EP4568560 A1 EP 4568560A1 EP 23754907 A EP23754907 A EP 23754907A EP 4568560 A1 EP4568560 A1 EP 4568560A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- patient
- data
- period
- health event
- time
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0031—Implanted circuitry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/024—Measuring pulse rate or heart rate
- A61B5/02405—Determining heart rate variability
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/024—Measuring pulse rate or heart rate
- A61B5/0245—Measuring pulse rate or heart rate by using sensing means generating electric signals, i.e. ECG signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
- A61B5/0538—Measuring electrical impedance or conductance of a portion of the body invasively, e.g. using a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
- A61B5/0816—Measuring devices for examining respiratory frequency
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
- A61B5/1118—Determining activity level
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
- A61B5/363—Detecting tachycardia or bradycardia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6802—Sensor mounted on worn items
- A61B5/681—Wristwatch-type devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/686—Permanently implanted devices, e.g. pacemakers, other stimulators, biochips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6887—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient mounted on external non-worn devices, e.g. non-medical devices
- A61B5/6898—Portable consumer electronic devices, e.g. music players, telephones, tablet computers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
- A61B5/7267—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems involving training the classification device
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
Definitions
- This disclosure generally relates to systems including medical devices and, more particularly, to monitoring of patient health using such systems.
- a variety of devices are configured to monitor physiological signals of a patient.
- Such devices include implantable or wearable medical devices, as well as a variety of wearable health or fitness tracking devices.
- the physiological signals sensed by such devices include as examples, electrocardiogram (ECG) signals, respiration signals, perfusion signals, activity and/or posture signals, pressure signals, blood oxygen saturation signals, body composition, and blood glucose or other blood constiyuent signals.
- ECG electrocardiogram
- such devices are configured to detect health events, such as episodes of cardiac arrhythmia or worsening of heart failure, based on the physiological signals.
- Example arrhythmia types include asystole, bradycardia, ventricular tachycardia, supraventricular tachycardia, wide complex tachycardia, atrial fibrillation, atrial flutter, ventricular fibrillation, atrioventricular block, premature ventricular contractions, and premature atrial contractions.
- the devices may store ECG and other physiological signal data collected during a time period including an episode as episode data.
- the devices may also store episode data quantifying the episodes, e.g., number and/or duration of episodes.
- the medical device may also store ECG and other physiological data for a time period as episode data in response to user input, e.g., from the patient or a caregiver.
- the disclosure describes techniques for determining a risk level of a health event based on changes, including sometimes subtle changes, in sinus rhythm over a period of time.
- the techniques include a computing system receiving ECG data, obtaining a plurality of heartbeat intervals from the ECG data, sampling a plurality of points for each respective heartbeat interval of the plurality of intervals, determining a difference between the slow-moving average and the fest-moving average for each sample point parameter, and determining a risk level of a health event for the patient based on the determined differences.
- Determining a risk level of a health event for the patient based at least in part on determining a difference between a slow-moving average and a fest-moving average for each sample point parameter for each respective heartbeat interval of the plurality of obtained heartbeat intervals from ECG data may provide for easier implementation on a device or server that may more efficiently determine a risk level of a health event by reducing parameters used to determine a risk level of a health event.
- determining a risk level of a health event for the patient based at least in part on determining a difference between a slow-moving average and a fest-moving average for each sample point parameter for each respective heartbeat interval of the plurality of obtained heartbeat intervals from ECG data may improve patient outcomes through more accurate and accessible predictive monitoring.
- providing insight or suggestions for intervention based on the determined risk level of a health event determined using techniques of this disclosure may provide for intervention and/or treatment of a patient before a serious health event occurs, which may reduce morbidity and improve patient care.
- the system described herein may remotely monitor ECG signals, such as with an ICM, identify changes in the ECG signal that indicate an acute health event is likely to occur in tire near future, and generate an output so intervention may occur before the acute health event occurs, which would improve patient outcomes and reduce morbidity of upcoming acute health events.
- a system comprises a memory; and processing circuitry coupled to the memory and configured to: receive electrocardiogram (ECG) data of a patient, wherein the ECG data is generated by one or more sensing devices of the patient based on physiological signals of the patient sensed by the one or more sensing devices; obtain a plurality of heartbeat intervals from the ECG data; sample a plurality of points for each respective heartbeat interval of the plurality of intervals; determine a slow-moving average for each sample point parameter of respective heartbeat intervals during a first period of time; determine a fast-moving average for each sample point parameter of respective heartbeat intervals dining a second period of time, the second period of time being less than the first period of time; determine a difference between the slow-moving average and the fast-moving average for each sample point parameter; and determine a risk level of a health event for the patient based on the determined differences.
- ECG electrocardiogram
- a method comprises receiving electrocardiogram (ECG) data of a patient, wherein the ECG data is generated by one or more sensing devices of the patient based on physiological signals of the patient sensed by the one or more sensing devices; obtaining a plurality of heartbeat intervals from the ECG data; sampling a plurality of points for each respective heartbeat interval of the plurality of intervals; determining a slow-moving average for each sample point parameter of respective heartbeat intervals during a first period of time; determining a fest-moving average for each sample point parameter of respective heartbeat intervals during a second period of time, the second period of time being less than the first period of time; determining a difference between the slow-moving average and the fest-moving average for each sample point parameter; and determining a risk level of a health event for the patient based on the determined differences.
- ECG electrocardiogram
- a system comprises a memory; and processing circuitry coupled to the memory and configured to: receive electrocardiogram (ECG) data of a patient, wherein the ECG data is generated by one or more sensing devices of the patient based on physiological signals of the patient sensed by the one or more sensing devices; obtain a plurality of heartbeat data from the ECG data; determine a slow-moving metric based on the heartbeat data during a first period of time; determine a fest-moving metric based on the heartbeat data during a second period of time, the second period of time being less than the first period of time; and determine a risk level of a health event for the patient based on the slow-moving metric and the fast-moving metric.
- ECG electrocardiogram
- a system comprises processing circuitry configured to receive parametric data for a plurality of parameters of a patient.
- the parametric data is generated by one or more sensing devices of the patient based on physiological signals of the patient sensed by the one or more devices.
- the processing circuitry is furth er configured to determine a training set of parametric data for training a model based on the parametric data of the patient, classify the training set of parametric data based on classification data collected automatically in response to detection of a trigger, and train the model with the classified training set of parametric data.
- a method comprises receiving parametric data for a plurality of parameters of a patient.
- the parametric data is generated by one or more sensing devices of the patient based on physiological signals of the patient sensed by the one or more devices.
- the method further comprises determining a training set of parametric data for training a model based on the parametric data of the patient, classifying the training set of parametric data based on classification data collected automatically in response to detection of a trigger, and training the model with the classified training set of parametric data.
- a system comprises processing circuitry configured to perform any of the methods described herein.
- a non-transitory computer readable storage medium comprises program instractions configured to cause processing circuitry to perform any of the methods described herein.
- FIG. 1 is a block diagram illustrating an example medical device system configured to predict health events, and to respond to such predictions, in accordance with one or more techniques of this disclosure.
- FIG. 2 is a block diagram illustrating an example configuration of the IMD of
- FIG. 3 is a conceptual side-view diagram illustrating an example configuration of the IMD of FIGS, l and 2.
- FIG. 4 is a block diagram illustrating an example configuration of an external device that operates in accordance with one or more techniques of the present disclosure.
- FIG. 5 is a block diagram illustrating an example computing system that operates in accordance with one or more techniques of the present disclosure.
- FIG. 6 is a flow diagram illustrating an example technique for training a machine learning model using training sets of parametric data classified based on automatically collected classification data.
- FIG. 7 is a flow diagram illustrating an example technique for automatically collecting classification data.
- FIG. 8 is a flow diagram illustrating an example technique for predicting a health event and responding to the prediction of the health event.
- FIG. 9 is a graph illustrating parametric data of a plurality of patient parameters over a time period around a stroke event.
- FIG. 10 is a graph illustrating timeseries values of moving averages of parametric data of a patient parameter.
- FIG. 11 is a chart illustrating experimentally-determined statistical significances of a plurality of patient parameters in predicting stroke.
- FIG. 12 is a chart illustrating experimentally-determined statistical significances of a plurality of patient parameters in predicting stroke.
- FIGS. 13A-13D are charts illustrating experimentally-determined statistical significances of a plurality of patient parameters in predicting stroke for different patient populations.
- FIGS. 14A-14D are charts illustrating experimentally-determined statistical significances of a plurality of patient parameters in predicting hospitalization for different patient populations.
- FIG. 15 is a chart illustrating AF burden pattern features for predicting stroke and health care utilization.
- FIG. 16A and 16B are diagrams illustrating AF burden patterns in patients who experience stroke or a health care utilization event, respectively, for various patient populations.
- FIG. 17 is a graph illustrating detected AT/AF time (burden) over the course of a monitoring period.
- FIG. 18 presents a scatterplot of terminal nodes by labeled HCU rate and percent of patients for balanced training data.
- FIG. 19 presents an example graphical illustration of patterns in AF burden data mapped for a single HCU patient.
- FIG. 20 presents a scatterplot of scored terminal nodes by labelled HCU rate and patient percent for an unbalanced validation set.
- FIG. 21 presents a Verm diagram of AF burden threshold counts for the validation set.
- FIG. 22 is a graph showing ECG data strips sampled nightly over a period of time in accordance with one or more techniques of the present disclosure.
- FIG. 23 is a graph illustrating four heartbeat intervals sampled from the ECG data strips shown in FIG. 22 in accordance with one or more techniques of the present disclosure.
- FIG. 24 is a graph illustrating the respective sampled heartbeat intervals shown in
- FIG. 23 normalized in length in accordance with one or more techniques of the present disclosure.
- FIG. 25 is a graph illustrating a value of fast-moving average (FMA), a slow- moving average (SLMA), and a value of a sample point, of the sampled intervals shown in FIG. 24, over a period of time, a difference between the FMA and the SLMA of the sample point, and a risk threshold over the period of time in accordance with one or more techniques of the present disclosure.
- FMA fast-moving average
- SLMA slow- moving average
- FIGS. 26-29 are graphs illustrating sample point averages over a period of time of flagged sample intervals in accordance with one or more techniques of the present disclosure.
- FIG. 30 is a flow diagram illustrating an example technique for predicting a health event in accordance with one or more techniques of the present disclosure.
- FIG. 31 is a chart illustrating methodology for rare event prediction using continuous monitoring data in accordance with one or more techniques of the present disclosure.
- External devices that may be used to non-invasively sense and monitor ECGs and other physiological signals include wearable devices with electrodes configured to contact the skin of the patient, such as patches, watches, or necklaces. Such external devices may facilitate relatively longer-term monitoring of patient health dining normal daily activities.
- Implantable medical devices also sense and monitor ECGs and other physiological signals, and detect health events such as arrhythmia episodes and worsening heart failure.
- Example IMDs include pacemakers and implantable cardioverter-defibrillators, which may be coupled to intravascular or extravascular leads, as well as pacemakers with housings configured for implantation within the heart, which may be leadless. Some IMDs do not provide therapy, such as implantable patient monitors.
- One example of such an IMD is the Reveal LINQTM Insertable Cardiac Monitor (ICM), available from Medtronic pic, which may be inserted subcutaneously.
- ICM Reveal LINQTM Insertable Cardiac Monitor
- Such IMDs may facilitate relatively longer-term monitoring of patients during normal daily activities, and may periodically transmit collected data, e.g., episode data for detected arrhythmia episodes, to a remote patient monitoring system, such as the Medtronic CarelinkTM Network.
- Acute heath events such a stroke and sudden cardiac arrest (SCA) have significant morbidity once they occur.
- This disclosure describes techniques of a system remotely monitoring ECG signals, such as with an ICM, identifying changes in the ECG signal that indicate an acute health event is likely to occur in the near future, and generating an output so intervention may occur before the acute health event occurs, which would improve patient outcomes and reduce morbidity of upcoming acute health events.
- the near future may be within 5 to 10 days. In some examples, the near future may be a variety of other time periods, either greater than or less than 5 to 10 days.
- FIG. 1 is a block diagram illustrating an example medical device system 2 configured to predict health events of a patient 4, and to respond to such predictions, in accordance with the techniques of the disclosure.
- the example techniques may be used with an IMD 10, which may be in wireless communication with an external device 12.
- IMD 10 is implanted outside of a thoracic cavity of patient 4 (e.g., subcutaneously in the pectoral location illustrated in FIG. 1).
- IMD 10 may be positioned near the sternum near or just below the level of the heart of patient 4, e.g., at least partially within the cardiac silhouette.
- IMD 10 includes a plurality of electrodes (not shown in FIG. 1), and is configured to sense an ECG via the plurality of electrodes.
- IMD 10 takes the form of the LINQTM ICM. Although described primarily in the context of examples in which the IMD takes the form of an ICM, the techniques of this disclosure may be implemented in systems including any one or more implantable or external medical devices, including monitors, pacemakers, or defibrillators.
- External device 12 is a computing device configured for wireless communication with IMD 10. External device 12 retrieves episode and other physiological data from IMD 10 that was collected and stored by IMD 10. In some examples, external device takes the form of a personal computing device of the patient or caregiver, such as a smartphone.
- system 2 also includes a sensor device 14 in wireless communication with external device 12. Sensor device 14 may include electrodes and other sensors to sense physiological signals of patient 4, and may collect and store physiological data and detect episodes based on such signals. In some examples, sensor device 14 is an external device wearable by patient 4. Sensor device 14 may be incorporated into the apparel of patient 14, such as within clothing, shoes, eyeglasses, a watch or wristband, a hat, etc. In some examples, sensor device 14 is a smartwatch or other accessory or peripheral for a smartphone external device 12.
- External device 12 retrieves episode and other physiological data from sensor device 14 that was collected and stored by sensor device 14.
- External device 12 may include a display and other user interface elements.
- external device 12 presents physiological data retrieved from IMD 10 and/or sensor device 14, and/or statistical representations thereof, to patient 4 or another user.
- External device 12 may communicate with IMD 10 and/or sensor device 14 according to the Bluetooth® or Bluetooth® Low Energy (BLE) protocols, as examples.
- BLE Bluetooth® or Bluetooth® Low Energy
- External device 12 may be configured to communicate with a computing system 20 via a network 16. External device 12 may be used to retrieve data from IMD 10 and sensor device 14, and may transmit the data to computing system 20 via network 16.
- the retrieved data may include values of physiological parameters measured by IMD 10 and sensor device 14, data regarding episodes of arrhythmia or other health events detected by IMD 10 and sensor device 14, and other physiological signals or data recorded by IMD 10 sensor device 14.
- the data retrieved from IMD 10 and sensor device 14 may include values of various patient parameters, and/or may be used by computing system 20 to determine values of patient parameters.
- the values of patient parameters may be referred to as patient parametric data. Patient parametric data may be retrieved and or determined on a periodic basis to produce periodic values, e.g., on a daily basis to produce daily values.
- Computing system 20 may comprise computing devices configured to allow users, e.g., clinicians treating patient 4 and other patients, to interact with data collected from IMDs 10 and sensor devices 14 of their patients.
- computing system 20 includes one or more handheld computing devices, computer workstations, servers or other networked computing devices.
- computing system 20 may include one or more devices, including processing circuitry' and storage devices, that implement a monitoring system 222 (FIG. 5).
- computing system 20 may receive ECG data, via IMD 10, obtain a plurality of heartbeat intervals from the ECG data over a period of time, sample or summarize a plurality of points for each respective heartbeat interval from the plurality of intervals, determine a difference between the slow-moving average and the fast-moving average for each sample point parameter, and determine a risk level of a health event for the patient based on the determined differences.
- each obtained heartbeat interval from the ECG data may be a single heartbeat interval or an average of a plurality of adjacent and/or neighboring heartbeats from the ECG data, such as an average of 10 adjacent or neighboring heartbeats.
- Monitoring system 222 may present parametric data of patients to clinicians to allow clinicians to remotely track and evaluate their patients. In some examples, monitoring system 222 may analyze the data and prioritize presentation of data or alerts for certain patients based on the analysis.
- Computing system 20, network 16, and monitoring system 222 may be implemented by the Medtronic CaretinkTM Network, in some examples.
- Network 16 may include one or more computing devices (not shown), such as one or more non-edge switches, routers, hubs, gateways, security devices such as firewalls, intrusion detection, and/or intrusion prevention devices, servers, computer terminals, laptops, printers, databases, wireless mobile devices such as cellular phones or personal digital assistants, wireless access points, bridges, cable modems, application accelerators, or other network devices.
- Network 16 may include one or more networks administered by service providers, and may thus form part of a large-scale public network infrastructure, e.g., the Interet.
- Network 16 may provide computing devices, such as computing system 20 and external device 12, access to the Internet, and may provide a communication framework that allows the computing devices to communicate with one another.
- network 16 may be a private network that provides a communication framework that allows computing system 20 and external device 12 to communicate with one another but isolates one or more of these devices or data flows between these devices from devices external to network 16 for security purposes.
- the communications between computing system 20 and external device 12 are encrypted.
- Computing system 20 may also retrieve data for patient 4 from electronic medical records (EMR) database 22.
- EMR database 22 may store electronic medical records, also referred to as electronic health records, for patient 4, which may be generated by various health care providers, laboratories, clinicians, insurance companies, etc. Although illustrated as a single database in FIG. 1, EMR database 22 may include various databases managed by various entities.
- EMR database 22 may store a medication history of the patient, a surgical procedure history of the patient, a hospitalization history of the patient, emergency or urgent care visit history of the patient, scheduled clinic visit history of the patient, one or more lab or other clinical test results for patient 14, a cardiovascular history of patient 14, or co-morbidities of patient 14 such as atrial fibrillation, heart failure, or diabetes, as examples.
- EMR database 22 may store medical images for patient 4, such as x-ray images, ultrasound images, echocardiograms, anatomical imagery, medical photographs, radiographic images, etc.
- the data stored in EMR database 22 may include the patient specific records for patient 4 and numerous other patients.
- tire data stored by EMR database 22 may include broader demographic information or population-type information for a plurality of patients.
- Monitoring system 222 may implement the techniques of this disclosure including developing an algorithm based on training sets of parametric data of a population of patients or subjects retrieved from IMDs 10 and external devices 14 of the population, and applying the algorithm to parametric data of an individual patient 4 to predict the occurrence of a clinically significant health event.
- monitoring system trains one or more machine learning (ML) models for prediction of the health event.
- the output of the ML models for a particular patient may be a level of risk of the health event, a probability of the health event occurring within a certain time, and/or whether the risk or probability satisfies a threshold.
- Example health events that may be predicted using the techniques of this disclosure include stroke, clinically significant AF requiring hospitalization or urgent care, and clinically significant episodes of symptomatic events, such as syncope or dizziness.
- Parametric data that may be useful for predicting such health events may include cardiac rhythm data, such as heart rate data and data related to atrial fibrillation (AF) or other arrhythmia episodes.
- AF data may include quantifications of AF, referred to as AF burden, as well as patterns of AF burden over a plurality of periods of time.
- Parametric data that may be useful for predicting such clinically significant health events may additionally or alternatively include patient activity data or any other patient data or signals described herein.
- Monitoring system 222 may also utilize data from EMR database 22 and/or data entered by the patient or a caregiver via external device 12 in conjunction with the parametric data from IMD 10 or sensor device 14.
- data from EMR database 22 and/or data entered by the patient or caregiver may be used as inputs to the ML model(s) or other health event prediction algorithms implemented by monitoring system 222.
- data from EMR database 22 and/or data entered by the patient or caregiver via external device 12 may provide classifications for training sets of parametric data from IMD 10 and sensor device 14 used to train one or more ML models to predict a health event.
- data from EMR database 22 and/or data entered by the patient or caregiver via external device 12 may indicate whether, when, and to what degree of severity patient 4 experienced the clinically significant health event.
- data may be correlated with the parametric data to create a training set of parametric data. After an initial training phase, such training sets may be used for reinforcement learning and, in some cases, personalization of the one or more ML models.
- the techniques are described herein as being performed by monitoring system 222, and thus by processing circuitry of computing system 20, the techniques may be performed by processing circuitry of any one or more devices or systems of a medical device system, such as computing system 20, external device 12, or IMD 10.
- the ML models may include, as examples, neural networks, deep learning models, convolutional neural networks, or other types of predictive analytics systems.
- FIG. 2 is a block diagram illustrating an example configuration of IMD 10 of FIG. 1.
- IMD 10 includes processing circuitry 50, sensing circuitry 52, communication circuitry 54, memory' 56, sensors 58, switching circuitry 60, and electrodes 16A, 16B (hereinafter “electrodes 16”), one or more of which may be disposed on a housing of IMD 10.
- memory 56 includes computer-readable instructions that, when executed by processing circuitry 50, cause IMD 10 and processing circuitry 50 to perform various functions attributed herein to IMD 10 and processing circuitry 50.
- Memory- 56 may include any volatile, non-volatile, magnetic, optical, or electrical media, such as a random-access memory (RAM), read-only memory (ROM), non-volatile RAM (NVRAM), electrically-erasable programmable ROM (EEPROM), flash memory, or any other digital media.
- RAM random-access memory
- ROM read-only memory
- NVRAM non-volatile RAM
- EEPROM electrically-erasable programmable ROM
- flash memory or any other digital media.
- Processing circuitry 50 may include fixed function circuitry and/or programmable processing circuitry. Processing circuitry' 50 may include any one or more of a microprocessor, a controller, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field-programmable gate array (FPGA), or equivalent discrete or analog logic circuitry. In some examples, processing circuitry 50 may include multiple components, such as any combination of one or more microprocessors, one or more controllers, one or more DSPs, one or more ASICs, or one or more FPGAs, as well as other discrete or integrated logic circuitry. The functions attributed to processing circuitry 50 herein may be embodied as software, firmware, hardware or any combination thereof.
- Sensing circuitry 52 may be selectively coupled to electrodes 16A, 16B via switching circuitry 60 as controlled by processing circuitry 50. Sensing circuitry 52 may monitor signals from electrodes 16A, 16B in order to monitor electrical activity of a heart of patient 4 of FIG. 1 and produce ECG data for patient 4. In some examples, processing circuitry 50 may identify features of the sensed ECG, such as heart rate, heart rate variability, intra-beat intervals, and/or ECG morphologic features, to detect an episode of cardiac arrhythmia of patient 4. Processing circuitry 50 may store the digitized ECG and features of the ECG used to detect the arrhythmia episode in memory 56 as episode data for the detected arrhythmia episode. Processing circuity 50 may also store parametric data in memory 56 including features of the ECG and data quantifying arrhythmia episodes, such as AF burden data.
- features of the sensed ECG such as heart rate, heart rate variability, intra-beat intervals, and/or ECG morphologic features
- Sensing circuitry 52 and/or processing circuitry 50 may be configured to detect cardiac depolarizations (e.g., P-waves of atrial depolarizations or R-waves of ventricular depolarizations) when the ECG amplitude crosses a sensing threshold.
- cardiac depolarization detection sensing circuitry 52 may include a rectifier, filter, amplifier, comparator, and/or analog-to-digital converter, in some examples.
- sensing circuitry' 52 may output an indication to processing circuitry 50 in response to sensing of a cardiac depolarization. In this manner, processing circuitry' 50 may receive detected cardiac depolarization indicators corresponding to the occurrence of detected R-waves and/or P- waves.
- Processing circuitry- 50 may use the indications for determining features of the ECG including inter-depolarization intervals, heart rate, and heart rate variability. Sensing circuitry 52 may also provide one or more digitized ECG signals to processing circuitry 50 for analysis, e.g., for use in cardiac rhythm discrimination and/or to identify and delineate features of the ECG, such as QRS amplitudes and/or width, or other morphological features. [0068] In some examples, sensing circuitry' 52 measures impedance, e.g., of tissue proximate to IMD 10, via electrodes 16. The measured impedance may vary based on respiration and a degree of perfusion or edema. Processing circuitry 50 may determine parametric data relating to respiration, perfusion, and/or edema based on the measured impedance.
- IMD 10 includes one or more sensors 58, such as one or more accelerometers, microphones, optical sensors, temperature sensors, and/or pressure sensors.
- sensing circuitry 52 may include one or more filters and amplifiers for filtering and amplifying signals received from one or more of electrodes 16A, 16B and/or other sensors 58.
- sensing circuitry 52 and/or processing circuitry' 50 may include a rectifier, filter and/or amplifier, a sense amplifier, comparator, and/or analog-to- digital converter.
- Processing circuitry 50 may determine parametric data, e.g., values of physiological parameters of patient 4, based on signals from sensors 58, which may be stored in memory' 56.
- processing circuitry 50 transmits, via communication circuitry 54, the parametric and episode data for patient 4 to external device 12 of FIG. 1, which may transmit the data to network 16 for processing by monitoring system 222 of computing system 20.
- Communication circuitry 54 may include any suitable hardware, firmware, software or any combination thereof for communicating with another device, such as external device 12. Under the control of processing circuitry 50, communication circuitry 54 may receive downlink Telemetry fiom, as well as send uplink telemetry to, external device 12 or another device with the aid of an internal or external antenna, e.g., antenna 26.
- the techniques for cardiac arrhythmia detection disclosed herein may be used with other types of devices.
- the techniques may be implemented with an extra-cardiac defibrillator coupled to electrodes outside of the cardiovascular system, a transcatheter pacemaker configured for implantation within the heart, such as the MicraTM transcatheter pacing system commercially available from Medtronic PLC of Dublin Ireland, an insertable cardiac monitor, such as the Reveal LINQTMICM, also commercially available from Medtronic PLC, a neurostimulator, or a drag delivery device.
- an extra-cardiac defibrillator coupled to electrodes outside of the cardiovascular system
- a transcatheter pacemaker configured for implantation within the heart
- an insertable cardiac monitor such as the Reveal LINQTMICM, also commercially available from Medtronic PLC
- a neurostimulator or a drag delivery device.
- sensor device 14 may be an external device such as a smartwatch, a fitness tracker, patch, or other wearable device.
- Sensor device 14 may be configured similarly to IMD 10 in the sense that it may include electrodes, sensors, sensing circuitry, processing circuitry, memory, and communication circuitry, and may function similarly to collect parametric data and communicate with external device 12.
- the sensors of and parametric data collected by IMD 10 and sensor device 14 may differ as described herein.
- FIG. 3 is a conceptual side-view diagram illustrating an example configuration of IMD 10.
- IMD 10 may include a leadless, subcutaneously- implantable monitoring device having a housing 18 and an insulative cover 74.
- Electrode 16A and electrode 16B may be formed or placed on an outer surface of cover 74.
- Circuitries 50-56 and 60, described above with respect to FIG. 2, may be formed or placed on an inner surface of cover 74, or within housing 18.
- antenna 26 is formed or placed on tire inner surface of cover 74, but may be formed or placed on the outer surface in some examples.
- Sensors 58 may also be formed or placed on the inner or outer surface of cover 74 in some examples.
- insulative cover 74 may be positioned over an open housing 18 such that housing 18 and cover 74 enclose antenna 26, sensors 58, and circuitries 50-56 and 60, and protect the antenna and circuitries from fluids such as body fluids.
- One or more of antenna 26, sensors 58, or circuitries 50-56 may be formed on insulative cover 74, such as by using flip-chip technology.
- Insulative cover 74 may be flipped onto a housing 18. When flipped and placed onto housing 18, the components of IMD 10 formed on the inner side of insulative cover 74 may be positioned in a gap 76 defined by housing 18.
- Electrodes 16 may be electrically connected to switching circuitry 60 through one or more vias (not shown) formed through insulative cover 74.
- Insulative cover 74 may be formed of sapphire (i.e., corundum), glass, parylene, and/or any other suitable insulating material.
- Housing 14 may be formed from titanium or any other suitable material (e.g., a biocompatible material).
- Electrodes 16 may be formed from any of stainless steel, titanium, platinum, iridium, or alloys thereof. In addition, electrodes 16 may be coated with a material such as titanium nitride or fractal titanium nitride, although other suitable materials and coatings for such electrodes may be used.
- FIG. 4 is a block diagram illustrating an example configuration of external device
- external device 12 takes the form of a mobile device, such as a mobile phone, a “smart” phone, a laptop, a tablet computer, or a personal digital assistant (PDA).
- external device 12 is a computing device of patient 4.
- external device 12 includes processing circuitry 80, storage device 82, communication circuitry 84, and a user interface 86.
- FIG. 4 may be any component or system that includes processing circuitry or other suitable computing environment for executing software instructions and, for example, need not necessarily include one or more elements shown in FIG. 4 (e.g., in some examples components such as storage device 82 may not be co-located or in the same chassis as other components).
- Processing circuitry' 80 in one example, is configured to implement functionality and/or process instructions for execution within external device 12.
- processing circuitry 80 may be capable of processing instructions, including applications 90, stored in storage device 82.
- Examples of processing circuitry 80 may include, any one or more of a microprocessor, a controller, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field-programmable gate array (FPGA), or equivalent discrete or integrated logic circuitry.
- DSP digital signal processor
- ASIC application specific integrated circuit
- FPGA field-programmable gate array
- Storage device 82 may be configured to store information within external device 12, including applications 90 and data 100.
- Storage device 82 in some examples, is described as a computer-readable storage medium.
- storage device 82 includes a temporary memory or a volatile memory. Examples of volatile memories include random access memories (RAM), dynamic random access memories (DRAM), static random access memories (SRAM), and other forms of volatile memories known in the art.
- RAM random access memories
- DRAM dynamic random access memories
- SRAM static random access memories
- Storage device 82 in one example, is used by applications 90 running on external device 12 to temporarily store information during program execution.
- Storage device 82 in some examples, also includes one or more memories configured for long-term storage of information, e.g. including non-volatile storage elements. Examples of such non-volatile storage elements include magnetic hard discs, optical discs, floppy discs, flash memories, or forms of electrically programmable memories (EPROM) or electrically erasable and programmable (EEPROM) memories.
- EPROM electrically programmable
- External device 12 utilizes communication circuitry 84 to communicate with other devices, such as IMD 10, sensor device 14, and computing system 20 of FIG. 1.
- Communication circuitry 84 may include a network interface card, such as an Ethernet card, an optical transceiver, a radio frequency transceiver, or any other type of device that can send and receive information.
- a network interface card such as an Ethernet card, an optical transceiver, a radio frequency transceiver, or any other type of device that can send and receive information.
- Other examples of such network interfeces may include 3G, 4G, 5G, and WiFi radios.
- External device 12 also includes a user interface 86.
- User interface 86 may be configured to provide output to a user using tactile, audio, or video stimuli and receive input from a user through tactile, audio, or video feedback.
- User interface 86 may include, as examples, a presence-sensitive display, a mouse, a keyboard, a voice responsive system, video camera, microphone, or any other type of device for detecting a command from a user, a sound card, a video graphics adapter card, or any other type of device for converting a signal into an appropriate form understandable to humans or machines, a speaker, a cathode ray tube (CRT) monitor, a liquid crystal display (LCD), or any other type of device that can generate intelligible output to a user.
- CTR cathode ray tube
- LCD liquid crystal display
- Example applications 90 executable by processing circuitry 80 of external device 12 include an IMD interface application 92, a sensor device interface application 94, a health monitor application 96, and a location service 98. Execution of IMD interface 92 by processing circuitry' 80 configures external device 12 to interface with IMD 10. For example, IMD interface 92 configures external device 12 to communicate with IMD 10 via communication circuitry' 84. Processing circuitry' 80 may retrieve IMD data 102 from IMD 10, and store IMD data 102 in memory 82. IMD interface 92 also configures user interface 86 for a user to interact with IMD 10 and/or IMD data 102.
- IMD interface 92 configures external device 12 to communicate with IMD 10 via communication circuitry 84.
- Processing circuitry 80 may retrieve IMD data 102 from IMD 10, and store IMD data 102 in memory 82.
- IMD interface 92 also configures user interface 86 for a user to interact with IMD 10 and/or IMD data 102.
- sensor device interface 94 configures external device 12 to communicate with sensor device 14 via communication circuitry 84, retrieve sensor device data 104 from sensor device 14, and store sensor device data 104 in memory 82.
- Sensor device interface 42 also configures user interface 86 for a user to interact with sensor device 14 and/or sensor device data 104.
- Health monitor 96 may be configured facilitate monitoring the health of patient 4 by a user, such as the patient or a caregiver. Health monitor 96 may present health information, such as at least portions of IMD data 102 and/or sensor device data 104, via user interface 86. Health monitor 96 may also collect information regarding the patient’s health from the user via user interface 86, and store the information as user recorded health data 106. In some examples, health monitor 96 present the user with a questionnaire or survey seeking health data 106 from the user.
- Health monitor 96 may present the surveys according to a schedule, in response to IMD data 102 and/or sensor device data 104 indicating that patient 4 experienced a health event, and/or based on a location of patient 4, e.g., in response to location service 98 indicating that patient 4 entered a geofence area defined by geofence data 108. Presenting surveys in response to health events may facilitate timely capture of user recorded health data 106 regarding the health event.
- geofence areas are defined around clinics, hospitals, or the like, and entry' into a such geofence area may similarly indicate that patient 4 experienced a health event meriting timely collection of user recorded health data 106.
- Processing circuitry 80 may also store the times and durations of patient entering a geofence area as geofence data 108.
- IMD data 102 and sensor device data 104 may include patient parametric data derived from sensed physiological signals as described herein.
- IMD data 102 may include periodic (e.g., daily) values of one or more of: heart rate, heart rate variability, one or more ECG morphological features or intrabeat intervals, AF and/or other arrhythmia burden (e.g., number, time, or percent time per period), respiratory rate, perfusion, and activity levels.
- sensor device data 104 may include one or more of: activity levels, walking/running distance, resting energy, active energy, exercise minutes, quantifications of standing, body mass, body mass index, heart rate, low, high, and/or irregular heart rate events, heart rate variability, walking heart rate, heart beat series, digitized ECG, blood oxygen saturation, blood pressure (systolic and/or diastolic), respiratory rate, maximum volume of oxygen, blood glucose, peripheral perfusion, and sleep patterns.
- user recorded health data 106 may include one or more of: exercise and activity data, sleep data, symptom data, medical history data, quality of life data, nutrition data, medication taking or compliance data, allergy data, demographic data, weight, and height.
- Symptom data may include times a patient experienced a symptom and their characterizations of the symptoms, such as palpitations, atrial flutter, AF, atrial tachycardia, syncope, or dizziness.
- Medical history data may relate to history of AF, stroke, chronic obstructive pulmonary disease (COPD), renal dysfunction, or hypertension, history of procedures, such as ablation or cardioversion, and healthcare utilization.
- Sensor device data 104 and/or user recorded health data 106 may include one or more of the types of data listed in Table 1 below.
- FIG. 5 is a block diagram illustrating an example configuration of computing system 20.
- computing system 24 includes processing circuitry 202 for executing applications 220 that include monitoring system 222 or any other applications described herein.
- Computing system 20 may be any component or system that includes processing circuitry or other suitable computing environment for executing software instructions and, for example, need not necessarily include one or more elements shown in
- FIG. 5 e.g., user interface devices 204, communication circuitry 206; and in some examples components such as storage device(s) 208 may not be co-located or in the same chassis as other components).
- computing system 20 may be a cloud computing system distributed across a plurality of devices.
- computing system 24 includes processing circuitry- 202, one or more user interface (UI) devices 204, communication circuitry 206, and one or more storage devices 208.
- Computing system 20 in some examples, further includes one or more application(s) 220 such as monitoring system 222, that are executable by computing system
- Processing circuitry 202 in one example, is configured to implement functionality and/or process instructions for execution within computing system 20.
- processing circuitry 202 may be capable of processing instructions stored in storage device 208.
- Examples of processing circuitry 202 may include any one or more of a microprocessor, a controller, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field-programmable gate array (FPGA), or equivalent discrete or integrated logic circuitry.
- DSP digital signal processor
- ASIC application specific integrated circuit
- FPGA field-programmable gate array
- One or more storage devices 208 may be configured to store information within computing device 20 during operation.
- Storage device 208 in some examples, is described as a computer-readable storage medium.
- storage device 208 is a temporary memory, meaning that a primary purpose of storage device 208 is not long-term storage.
- Storage device 408, in some examples, is described as a volatile memory, meaning that storage device 408 does not maintain stored contents when the computer is turned off. Examples of volatile memories include random access memories (RAM), dynamic random access memories (DRAM), static random access memories (SRAM), and other forms of volatile memories known in the art.
- RAM random access memories
- DRAM dynamic random access memories
- SRAM static random access memories
- storage device 208 is used by software or applications 220 running on computing system 20 to temporarily store information during program execution.
- Storage devices 208 may further be configured for long-term storage of information, such as applications 220 and data 230.
- storage devices 208 include non-volatile storage elements. Examples of such non-volatile storage elements include magnetic hard discs, optical discs, floppy discs, flash memories, or forms of electrically programmable memories (EPROM) or electrically erasable and programmable memories (EEPROM).
- EPROM electrically programmable memories
- EEPROM electrically erasable and programmable memories
- Computing system 20 also includes communication circuitry 206 to communicate with other devices and systems, such as IMD 10 and external device 12 of FIG. 1.
- Communication circuitry 206 may include a network interface card, such as an Ethernet card, an optical transceiver, a radio frequency transceiver, or any other type of device that can send and receive information.
- network interfaces may include 3G, 4G, 5G, and WiFi radios.
- Computing system 20 also includes one or more user interface devices 204.
- User interface devices 204 may be configured to provide output to a user using tactile, audio, or video stimuli and receive input from a user through tactile, audio, or video feedback.
- User interface devices 204 may include, as examples, a presence-sensitive display, a mouse, a keyboard, a voice responsive system, video camera, microphone, or any other type of device for detecting a command from a user, a sound card, a video graphics adapter card, or any other type of device for converting a signal into an appropriate form understandable to humans or machines, a speaker, a cathode ray tube (CRT) monitor, a liquid crystal display (LCD), or any other type of device that can generate intelligible output to a user.
- a presence-sensitive display a mouse, a keyboard, a voice responsive system, video camera, microphone, or any other type of device for detecting a command from a user
- a sound card a video graphics adapter card
- LCD liquid crystal display
- Applications 220 may also include program instructions and/or data that are executable by processing circuitry 202 of computing system 20 to cause computing system 20 to provide the functionality ascribed to it herein.
- Example applications 220 may include monitoring system 22.
- Other additional applications not shown may alternatively or additionally be included to provide other functionality described herein and are not depicted for the sake of simplicity.
- computing system 20 receives
- IMD data 102 IMD data 102, sensor device data 104, user recorded health data 106, and geofence data 108 from external device 12 via communication circuitry- 206.
- Processing circuitry 202 stores these as data 230 in storage devices 208.
- Computing system 20 may also receive EMR data 230 from EMR database 22 (FIG. 1) vis communication circuitry 206, and store EMR data 230 in storage device 208.
- EMR data 230 may include, for each of a plurality of patients or subjects a medication history', a surgical procedure history, a hospitalization history, emergency or urgent care visit history, scheduled clinic visit history, one or more lab or other clinical test results, a procedure history, a cardiovascular history, or co-morbidities such as atrial fibrillation, heart failure, syncope, or diabetes, as examples.
- EMR data 230 may include medical images, such as x-ray images, ultrasound images, echocardiograms, anatomical imagery-, medical photographs, radiographic images, etc.
- Monitoring system 222 may implement the techniques of this disclosure including developing an algorithm based on training sets of parametric data, e.g., from IMD data 102 and sensor device data 104, and in some cases user recorded health data 106 and EMR data 230, of a population of patients or subjects, and applying the algorithm to parametric data of an individual patient 4 to predict the occurrence of a clinically significant health event.
- monitoring system 222 trains one or more machine learning (ML) models 224 for prediction of the health event.
- ML machine learning
- the output of the ML models for a particular patient may be a level of risk of the health event, e.g., a probability of the health event, a level of risk or probability of the health event occurring within a certain predetermined time period, and/or whether tire risk or probability satisfies a threshold.
- the plurality of patient parameters may include AF burden, one or more activity parameters, and/or any of the physiological parameters described herein.
- monitoring system 222 may derive features from the parametric data, and apply the features as inputs to the algorithm, e.g., ML model 224, to determine the risk level.
- One or more of the features may be AF burden features.
- One or more of the features may be AF burden pattern features.
- An AF burden pattern feature may quantify a pattern of AF burden over a plurality' of periods including the current period for which monitoring system 222 is determining the risk level.
- AF burden patterns including a change, e.g., spike or increase, in AF relative to an overall AF burden trend may be associated with an increased risk of a health event, such as a stroke of other clinically significant episode related to cardiovascular health.
- monitoring system 222 determines the AF burden pattern feature by comparing, e.g., determining a difference or ratio between, a current AF burden value and an average, e.g., mean or median, of previous AF burden values.
- the current value may be a single value for the current period of a shorter-term average of values including the current period and a number of preceding periods.
- the average value may be a longer-term average of previous values, e.g., including more values and/or values from further in the past, which may not include the current period value.
- the features include a patient activity feature, such as a daily activity level, a daytime or nighttime activity level, or a change in such an activity level relative to a baseline or trend in activity levels.
- the health event may be any clinically significant health event.
- the health event may be a cardiovascular event.
- the health event may be a stroke.
- the health event is a health care utilization event, such as a hospitalization.
- the health event comprises a symptomatic event, such as clinically significant syncope or dizziness.
- Monitoring system 222 may receive ECG data of patient 4, which may be generated by one or more sensing devices, such as IMD 10, of the patient based on physiological signals of the patient sensed by the one or more sensing devices, such as IMD 10.
- Monitoring system 222 may obtain a plurality of heartbeat intervals from the ECG data over a period of time, sample or summarize a plurality of points for each respective heartbeat interval from the plurality of intervals, and normalize the plurality of sampled or summarized points to a common length for each respective heartbeat interval of the plurality of intervals.
- each obtained heartbeat interval from the ECG data may be a single heartbeat interval or an average of a plurality of adjacent and/or neighboring heartbeats from the ECG data, such as, for example, an average of 10 adjacent or neighboring heartbeats.
- Monitoring system 222 may determine a slow-moving average for each sample point parameter of respective heartbeat intervals using one period of time and determine a fast-moving average for each sample point parameter of respective heartbeat intervals using a second period of time. The second period of time of the fast-moving average is less than the first period of time of the slow-moving average.
- Monitoring system 222 may determine a difference between the slow-moving average and the fast-moving average for each sample point parameter and determine a risk level of a health event for the patient based on the determined differences.
- monitoring system 222 may determine a comparison value for each sample point parameter by comparing an absolute value of the difference between the slow-moving average and the fast-moving average for each sample point parameter to a difference threshold and determine the risk level of the health event for the patient based on the comparison values for each sample point parameter.
- Monitoring system 222 may generate an output to indicate the determined risk level of the health event.
- monitoring system 222 may generate suggested responses, such as treatment, changes in medication, suggestion to go to the hospital, to be output in response to determining the risk level of the health event.
- serious health events such as stoke, MI, or SCA, may be treated before the health event occurs, which may provide greater care for a patient and/or reduce healthcare costs.
- Monitoring system 222 may initially train ML model 224 with parametric data collected from one or more populations of patients, e.g., during a clinical study.
- monitoring system 222 may classify the training sets of parametric data based on classification data 232 collected automatically in response to detection of a trigger, which may reduce the cost or manpower overhead associated with the clinical study.
- processing circuitry 202 executing monitoring system 222 collects the classification data 232.
- classification data is additionally or alternatively collected by other processing circuitry of system 2 (FIG. 1), such as processing circuitry 80 of external device 12 (FIG. 4), and received by computing system 20 from the other processing circuitry.
- Classification data 232 includes data indicative of an endpoint for the training set of parametric data, e.g., indicative of whether the patient experienced the health event or not.
- Classification data 232 may include data from user recorded health data 106, geofence data 108, and/or EMR data 230 indicative of an endpoint for a patient.
- any one or more of IMD 10, sensor device 14, external device 12, or computing system 20 may detect the trigger for collection of classification data 232.
- tire trigger is a geofence event, e.g., detected by external device 12 indicating that the patient went to a hospital or clinic for a threshold amount of time.
- external device 12 or computing system 20 may present a survey to the patient to collect information regarding the visit, e.g., confirming the visit and regarding the health issue(s) addressed, as user recorded health data 106 and classification data 230.
- the trigger comprises a feature of the parametric data for the patient satisfying a criterion, e.g., indicating that the patient may have experienced the health event.
- a trigger may be AF burden meeting or exceeding a threshold.
- Other example triggers may include a feature of any physiological parameter described herein meeting a threshold value.
- the trigger feature may be included within a training set of features used to train ML model 224, e.g., a set of features from which monitoring system 222 may choose to be input features based on their predictive value for the health event.
- monitoring system 222 or other processing circuitry' of system 2 may collect classification data 230.
- the collection of classification data 232 may be via a survey as discussed above, or by checking geofence data 108 and/or EMR data 230 to identify a time proximate hospital or clinic visit indicative of tire occurrence of the health event.
- monitoring system 222 may apply the ML model to parametric data, e.g., IMD data 102 and sensor device data 104, of a particular patient, such as patient 4, to determine a risk level that the patient with experience the health event.
- monitoring system 222 may determine whether risk level of the health event satisfies a criterion, e.g., meets or exceeds a threshold risk level.
- Monitoring system 222 may take one or more actions based on determining that the risk level satisfied the criterion, e.g., as described with respect to FIG. 8.
- monitoring system 222 may additionally or alternatively implement monitoring system 222, e.g., using ML model 224 trained based on population parametric data and, in some examples, personalized based on parametric data of patient 4.
- ML model 224 may include, as examples, neural networks, deep learning models, convolutional neural networks, or other types of predictive analytics systems.
- the techniques of this disclosure are described primarily with respect to examples including ML model 224, in some examples the techniques may be implemented with different models or algorithms that do not necessarily require machine learning, such as linear regression, trend analysis, decision trees, or thresholds, as examples.
- FIG. 6 is a flow diagram illustrating an example technique for training a machine learning model using training sets of parametric data classified based on automatically collected classification data.
- monitoring system 222 receives parametric data, such as IMD data 102 and sensor device data 104, of a plurality of patients (300).
- Monitoring system 222 determines training sets of the parametric data (302).
- Monitoring system 222 classifies the training sets of parametric data based on automatically collected classification data, as discussed above with reference to FIG. 5 (304).
- Monitoring system 222 trains ML model 224 with the classified training sets of parametric data (306)
- FIG. 7 is a flow diagram illustrating an example technique for automatically collecting classification data.
- monitoring system 222 collects parametric data of a patient, e.g., among a plurality of patient during a clinical study and ML model training phase (400).
- monitoring system determines whether trigger occurred (402).
- example triggers include a feature in the parametric data satisfying a criterion or a geofence event.
- a geofence event may be an event where a patient is within a geofenced area (e.g., an area near or around a hospital, urgent care clinic, and/or healthcare provider) for longer than a threshold time.
- the patient being with the geofenced area for longer than a threshold hold time may be evidence of unplanned or planned healthcare utilization.
- Examples of features in the parametric data satisfying a criterion include AF burden or other features derived from an ECG, e.g., heart rate or heart rate variability, exceeding a threshold, and/or a patient activity' feature felling below a threshold. If the trigger did not occur (NO of 402), monitoring system 222 may continue to receive parametric data of the patient and monitor for the trigger (400, 402).
- AF burden or other features derived from an ECG e.g., heart rate or heart rate variability
- monitoring system 222 collects classification data 232 (404).
- example classification data 232 may include user recorded health data 106 from a survey delivered to the patient in response to the trigger, or time proximate geofence data 108 (in the case of a parametric data feature trigger) or EMR data 230 indicating the patient visited a hospital or clinic and, in some cases, that the health event occurred.
- Monitoring system 222 associates the classification data 232 with the parametric data for eventual classification of a training set of parametric data (406).
- FIG. 8 is a flow diagram illustrating an example technique for predicting a health event and responding to the prediction of the health event.
- example health events include stroke, hospitalization or other health care utilization, or symptomatic events, such as symptomatic AF or other cardiovascular events.
- monitoring system 222 receives parametric data, e.g., IMD data 102 and sensor device data 104, for patient 4 (500).
- parametric data e.g., IMD data 102 and sensor device data 104
- Monitoring system 222 applies features derived from the parametric data to ML model 224 (502).
- the features may include an AF feature, such as an AF burden pattern feature, and, in some cases, a patient activity feature or other feature derived from another physiological signal.
- Monitoring system 222 determines a risk level of the health event based on the application of the features to ML model 224, e.g., ML model 224 outputs a probability of the health event occurring with a predetermined period of time, such as a number of days.
- Monitoring system 222 determines whether the risk level of the health event satisfies a criterion, e.g., meets or exceeds a threshold (504).
- monitoring system 222 continues to receive parametric data and apply features to ML model 224, e.g., on a period by period basis (500, 502). Based on the risk level satisfying the criterion (YES of 504), monitoring system 222 may perform one or more of the optional actions illustrated by FIG 8 (506-512).
- Monitoring system 222 may change a sensing behavior of system 2 (506). For example, monitoring system 222 may direct IMD 10 and/or sensing device 104 to employ more sensitive setting for sensing circuitry' 52 or sensors 58, sample physiological signals at a higher rate, and or make periodic measurements at a greater frequency.
- monitoring system 222 may provide an instruction to patient 4 to take a medication or modify the taking of a medication (508).
- the medication may be an anticoagulant.
- the instruction may be to take a pro re nata dose of the medication or change a dosage of the medication.
- monitoring system 222 may prioritize patient 4, or the portions of parametric data associated with the risk level of tire health event, in a notification for a clinician treating patient 4 (810).
- Monitoring system 222 implementing the techniques of this disclosure may advantageously reduce the burden of treating patients by prioritizing patients and/or patient data in their notification from system 2 based on the risk level satisfying a criterion indicating a clinically significant risk of the health event.
- monitoring system 222 reduces burden by determining which rhythms should be transmitted or alerted to the patient and/or clinician, e.g., presents a clinically relevant patient report that adjudicates symptoms.
- monitoring system 222 may determine a classification for the parametric data associated with the risk level of the health event, and create a training set of parametric data for reinforcement training of ML model 224 and/or personalization of ML model 224 for patient 4, e.g., to create a patient-specific version of ML model 224 (512).
- Monitoring system 222 may utilize any of the techniques described herein, e.g., with respect to FIG. 7, to collect classification data 232 for classifying the training set of parametric data.
- Health monitor 96 executed by processing circuitry 80 of external device may implement portions of the techniques described with respect to FIGS. 6-8. For example, health monitor 96 may present surveys and collect answers from patient 4, present instructions to take medication to patient 4, and provide enable messaging between patient 4 and a clinician.
- health monitor 96 can follow a pre-determined protocol to automatically push patient actions based on specific, detected patterns of parametric data. For example, health monitor 96 may see a predetermined clinically significant degree of AF burden and recommend modifications to a patient’s anticoagulation medication. As discussed above, the actions may additionally or alteratively be pushed based on the risk level of the health event satisfying a criterion.
- computing system 20 may provide an interface for a clinician via a web interface or user interface devices 204 to specify the parametric data features or risk level criterion that would trigger clinical action, e.g., AF duration lasting longer than 1 hour or probability of stroke exceeding a threshold probability, and the clinical action that the patient would need to take, such as an up titration of anticoagulation medications.
- health monitor 96 may provide a pro re nata (PRN) medication request.
- health monitor 96 may have a communication tab and also a priority status that would require the action to be acknowledged before allowing patient 4 to move on to other features of health monitor 96, such as viewing parametric data of patient 4.
- FIG. 9 is a graph illustrating parametric data of a plurality of patient parameters over a time period around a stroke event (time 0).
- the patient parameters include a patient activity parameter (Activities of Daily Living, related to an amount of patient motion exceeding a threshold during daytime hours), heart rate variability (HRV), night heart rate, day heart rate, and time in AF (or AF burden).
- HRV heart rate variability
- AF or AF burden
- time in AF and the heart rate related parameters all increase, and patient activity decreases, in the days leading up to the stroke.
- FIG. 10 is a graph illustrating timeseries values of moving averages of parametric data of a patient parameter.
- the patient parameter is Activities of Daily Living, although similar techniques may be applied to any other patient parameter described herein.
- FIG. 10 illustrates a technique for quantifying a feature related to an excursion of a patient parameter from its baseline or trend, which may be indicative of an increased risk of the health event.
- monitoring system 222 summarizes a trend with at least two simple moving averages (SMAs), and uses a comparison or offset of the two SMAs to capture a clinically significant change in the patient parameter.
- SMAs simple moving averages
- One SMA may be a shorter-term SMA and the other a longer-term SMA, e.g., that includes less recent values of the patient parameter than the shorter term SMA.
- Patient parameter values occurring within a predetermined number of day's of the health event, e.g., stroke, may be identified.
- Under-sample controls may be 1: 1 with cases, and all offsets and covariates may be evaluated in one model.
- Monitoring system 22 may compare goodness-of-fit for each variable (patient parameter) to determine relative importance of the variables.
- FIG. 11 is a chart illustrating experimentally-determined statistical significances of a plurality of patient parameters in predicting stroke.
- the patient parameters in the example of FIG. 11 are AF burden (AFB), day heart rate (DHR), activities of daily living (ADL), night heart rate (NHR), and heart rate variability (HRV).
- the statistical significances illustrated in FIG. 11 were determined based on parametric data collected from a plurality of patients including patients that suffered a stroke. As illustrated in FIG. 11, AF burden was found to be a significantly better predictor of stroke than the other patient parameters.
- FIG. 12 is another chart illustrating experimentally-determined statistical significances of a plurality of patient parameters in predicting stroke.
- FIG. 12 is similar to FIG. 11, but includes additional patient parameters. In particular, FIG.
- FIGS. 13A-13D are charts illustrating experimentally-determined statistical significances of a plurality of patient parameters in predicting stroke for different patient populations.
- FIG. 13A illustrates the statistical significances of the plurality of patient parameters in predicting stroke fbr patients with prior AF ablation.
- FIG. 13B illustrates tire statistical significances of the plurality of patient parameters in predicting stroke for patients with prior AF management.
- FIG. 13C illustrates the statistical significances of the plurality' of patient parameters in predicting stroke for patients with prior stroke.
- FIG. 13D illustrates the statistical significances of the plurality of patient parameters in predicting stroke for patients in whom AF is suspected by not confirmed.
- FIGS. 14A-14D are charts illustrating experimentally-determined statistical significances of a plurality of patient parameters in predicting hospitalization (a subset of health care utilization) for different patient populations.
- FIG. 14A illustrates the statistical significances of the plurality of patient parameters in predicting stroke for patients with prior AF ablation.
- FIG. 14B illustrates the statistical significances of the plurality of patient parameters in predicting stroke for patients with prior AF management.
- FIG. 14C illustrates the statistical significances of the plurality of patient parameters in predicting stroke for patients with prior stroke.
- FIG. 14D illustrates the statistical significances of the plurality of patient parameters in predicting stroke for patients in whom AF is suspected by not confirmed.
- FIG. 15 is a chart illustrating analysis of AF burden patter features for predicting stroke and health care utilization (HCU). The analysis indicates that for both stroke and HCU, a spike in AF burden, in some cases paired with a low patient activity level, is predictive of the event occurring within a timeframe.
- FIG. 16A and 16B are diagrams illustrating AF burden patterns in patients who experience stroke or a health care utilization event, respectively, for various patient populations.
- AF burden patterns such as those illustrated in FIGS. 16A and 16B signal subclinical changes that indicate periods of heightened risk for stroke and HCU.
- a patient was labeled as having an occurrence of HCU if their claims history included at least one encounter from an in- or outpatient hospital, emergency room, or ambulatory surgical center with a cardiovascular DRG or diagnosis code.
- the first occurrence of HCU was recorded if a patient had multiple utilizations.
- ICM-based diagnostic parameters evaluated in the study included daily total AT/AF burden (milliseconds/day), total patient activity, e.g., time with supra-threshold patient motion (minutes/day), average ventricular rate (night and day), and HRV. Patients with less than 21 days of daily follow-up after implant, or with a gap in follow-up greater than or equal to 30 days, were excluded from the cohort. Missing data resulting from a gap in daily follow-up was interpolated by forward-filling the last known value for each diagnostic parameter.
- Follow-up history was limited to two years unless there was an HCU, in which case follow-up ended the day prior to the event. Patients without any device-detected time in AT/AF within the two-year follow-up period were excluded from the cohort.
- each parameter at each patient follow-up date, was evaluated as a cumulative moving average (CMA) from the day after implant and as an SMA of different historical periods (1, 2, 3, 5, 8, 13, and 21 days) starting 21 days after implant.
- CMAa_b denoted the difference between SMAa and SMAb where the longer period SMA is subtracted from the shorter period SMA (i.e., a ⁇ b).
- SMAp_ c An offset of period p with its respective CMA was denoted as SMAp_ c .
- FIG. 17 is a graph illustrating detected AT/AF time (burden) over the course of a monitoring period.
- the vertical bars illustrate AF burden (AT/AF time) for sub-periods, in this case days, during which the patient experienced AT/AF.
- the graph of FIG. 17 further includes three trend lines illustrating, respectively, the CMA of AF burden 600, the 21 -day SMA of AF burden 602, and the difference between the 21-day SMA and the CMA of AF burden 604.
- Each split for a terminal node was recorded as a 3-tuple, [predictor name, comparison, index], along with its respective HCU rate and patient count for both training and validation sets.
- Each split was saved as a separate entry' if a node had multiple splits. In such a case, the utilization rates and patient counts would be tire same for all splits in each node.
- a scatterplot of decision tree terminal nodes showing the relationship between labeled HCU rate and the percent of patients was used to identify patterns in the AF burden classification tree structure that would stratify healthcare event risk.
- the algorithm for defining these patterns was:
- Steps 3.ii - 6 If the area is not unique to Time in AT/AF, repeat Steps 3.ii - 6 until the modal predictor is selected in at least 10% of all classification trees.
- an AF burden pattern as the 3-tuples having a selection rate above the elbow point identified in the preceding step.
- FIG. 18 presents a scatterplot of 50,751 terminal nodes by labeled HCU rate and percent of patients for the balanced training data.
- a point on a plot represents a unique terminal node.
- a single node can be represented across diagnostic parameters when its definition includes multiples splits with a different parameter for each split (e.g., time in AT/AF > 1 hour & daily activity ⁇ 100 minutes & nighttime heart rate > 80 beats per minute).
- Three local maxima were identified and denoted as shaded areas A, B and C. Missing (A & C) or infrequent (B) nodes for daily activity and heart rate parameters suggest the areas are largely defined by Time in AT/AF.
- Area D is derived from the analysis of areas A, B & C and is defined later in the results.
- Table 2 presents a summary of the top five splits by area. Splits with a selection rate above their respective elbow point are in bold. Together, these highlighted splits define the AF burden patter for a given area.
- Patter A is defined by an AF burden CMA less than approximately 1 second. The patter is present in all 3,000 decision trees and describes the follow-up period prior to the first detection of AT/AF (77% of occurrences) and the period of relative sinus rhythm recovery after device detected AT/AF (23% of occurrences).
- Patter C is defined by an AF burden CMA greater than approximately 1 second and an AF burden 21-day SMA that is approximately greater than its historical average. The pattern is present in 25% of all decision trees and describes a relative spike or increasing trend in daily AF burden.
- Patter B is defined by an AF burden CMA greater than approximately 1 second, but unlike pattern C, it has a decreasing AF burden 21-day SMA that is less than its historical average.
- the increasing 1-day SMA (daily burden) relative to the 21 - day SMA suggests that patter C signals a period of sporadic, below average burden, relative to the patient, that can occur after a period of elevated burden.
- FIG. 19 presents an example graphical illustration of these patterns in AF burden data mapped for a single HCU patient.
- Labeled HCU rate and patient percent were calculated on tire training data for AF burden quantity and duration thresholds.
- the quantity threshold was defined as daily AF burden greater than 5% (72 minutes); the duration threshold was defined as continuous AF greater than one hour.
- the log odds event rate was 0.369 and 0.386 and the patient percent was 12.9% and 7.6% for the respective thresholds.
- Table 2 Area D presents a summary of the top five splits in the terminal node scatterplot where the log odds event rate was greater than 0.369 and the percent of patients was greater than 12.9%.
- the top three splits define a partial substructure of pattern C where the CMA of daily activity drops below 76 minutes. When applied to a balanced training set, pattern D is selected 10.4% of the time and has a log odds ratio of 0.368, a value that is not statistically different from the other log odds ratios (Poisson regression, p > 0.5 for all threshold coefficients).
- FIG. 20 presents a scatterplot of scored terminal nodes by labelled HCU rate and patient percent for the unbalanced validation set.
- the overall distribution is similar in shape to the training data (FIG. 18). Different shades of color show dififerentthreshold patterns with the lightest shaded points representing nodes not covered by a pattern.
- AF burden patterns (A-C) provide broad coverage of the terminal node distribution with clear segmentation of event risk (B versus A, odds ratio (OR) 3.82, 95% CI 3.59-4.07; C versus A, OR 8.25, 95% CI 7.84- 8.69).
- Including a daily activity threshold (D) provides more specific coverage with the greatest risk for HCU among AF burden patterns (D versus A, OR 11.66, 95% CI 10.63- 12.79).
- FIG. 21 presents a Venn diagram of AF burden threshold counts for the validation set.
- Table 3 (below) presents statistics for each threshold and their mutually exclusive subsets.
- Atestfor odds ratio differences using Poisson regression showed a statistically significant coefficient for the intersection of all three thresholds (p ⁇ 0.10); the remaining coefficients were not statistically different (p > 0.10 for all coefficients).
- Count indicates the number of times the threshold was met; Events, the number of labeled HCUs; Odds, the ratio of event count to threshold count divided by the group mean event rate for the validation set; Patients, the number of patients with at least one day meeting the threshold as a percent of total patients in the validation set; Follow-ups, the number of days meeting the threshold as a percent of total follow-up days for patients with at least one occurrence of the threshold. Note: counts are mutually exclusive per followup days, not by patient. A patient may experience different thresholds across follow-up days. Therefore, patient and follow-up percentages will not sum to 100%.
- AF burden patterns in the study confirm the correlation between increased burden and risk and, more particularly, that a growing trend in AF burden (e.g., daily) over time is associated with a greater risk for HCU, especially when accompanied with a decline in daily activity.
- Patterns for AF burden amounts less than approximately 1-hour predict healthcare events on par with quantity and duration thresholds greater than 1-hour.
- AF burden patterns proved additional event capture that complements quantity and duration thresholds.
- AF burden as a risk factor for HCU is relative to a patient’s historical burden.
- the study illustrates the value of AF burden and patient activity as parametric data from which features may be derived and then applied to an algorithm or model to determine a likelihood of an event, such as an HCU event, as described herein.
- the features derived from AF burden may include AF burden patter features, such as a change, e.g., spike or increase, in AF burden relative to an overall AF burden trend.
- AF burden pattern features may include one or more offsets between SMAs for different look-back periods and/or between an SMA for a look-back period and a CMA.
- the model to which such features are applied may be machine learned or rules-based, e.g., involving decision trees and/or thresholds.
- Monitoring system 222 may determine a risk level of a health event based on changes, including sometimes subtle changes, in ECG data, such as changes in sinus rhythm, over a period of time.
- monitoring system 222 may receive ECG data of patient 4.
- FIG. 22 illustrates an example in which monitoring system 222 receives strips of ECG data of patient 4.
- the strips of ECG data are 10- seconds in length and were sampled nightly from April 27 th to July 5 th .
- the length of the ECG strip recording or the number of heartbeat intervals may vary.
- the time of day for each ECG recording and the number of days used for ECG data comparison may vary as well.
- FIG. 23 illustrates heartbeat intervals sampled from the ECG data strips shown in FIG. 22.
- the heartbeat intervals correspond to an RR- interval.
- monitoring system 222 may sample intervals from a strip of ECG data that correspond to one heartbeat or summarized intervals from a strip of ECG data into a single heartbeat interval. As shown in FIG. 22, the sampled heartbeat intervals over the period of days are arranged on the graph to be compared. In some examples, monitoring system 222 may take each sampled or summarized interval at the same time of day so that the sampled intervals may be compared. For example, FIG. 23 shows each sampled interval being taken at 00:05:00 for each respective day.
- each obtained heartbeat interval from the ECG data may be a single heartbeat interval or an average of a plurality of adjacent and/or neighboring heartbeats from the ECG data, such as, for example, an average of 10 adjacent or neighboring heartbeats.
- sampled or summarized heartbeat intervals may have different interval lengths for a variety of reasons, such as due to a patient having a varying heart rate on different days.
- FIG. 24 illustrates monitoring system 222 normalizing the respective sampled heartbeat intervals shown in FIG. 23 to have a same interval length to be compared.
- monitoring system 222 may sample each respective heartbeat interval at a number of points, such as 400 points, so monitoring system 222 may compare each point in a normalized heartbeat interval to a corresponding respective point overtime. For example, monitoring system 222 may compare point 100 for the sampled heartbeat intervals of April 27 th to July 5 th to each other to track how the value of point 100 changes overtime.
- 400 sample points were taken for each sampled interval and normalized to be compared.
- the number of sample points may be greater than 400 or less than 400.
- the number of sample points may be between 200 and 2000 sample points per sample interval, such as 200, 300, 400, 500, 600, 700, 800, 900 or 1000 sample points per sampled interval.
- the number of samples points may be other amounts as well.
- FIG. 25 illustrates an example of monitoring system 222 determining a value of a fest-moving average (FMA) of sample point 100, a slow-moving average (SLMA) of sample point 100, and a value of each sample point itself of sample point 100, of the sampled intervals shown in FIG. 24, over a period of time (e.g., fiom April 27 th to July 5 th ).
- monitoring system 222 summarizes a trend with at least the FMA and SLMA and uses a comparison or offset of the FMA and SLMA to capture a clinically significant change in the patient parameter.
- the FMA is a shorter period moving average than the SLMA.
- the longer term SLMA includes less recent values of the patient parameter than the shorter period FMA.
- a period of time for the SLMA may be 20 days while the period of time for the FMA may be 8 days.
- a period of time for the SLMA may be 25 days while the period of time for the FMA may be 10 days.
- the period of time for the SLMA and the FMA may be a variety of different amounts of days, but the period of time for the SLMA is greater than the period of time for the FMA.
- the period of time for the SLMA may be 10 days more than the period of time for the FMA.
- the period of time for the SLMA may be 8, 12, 15, 17, 20, 30, or 50 days more than the period of time for the FMA. The more recent days may be included in both the SLMA and FMA.
- FIG. 25 further illustrates monitoring system 222 determining a difference (labeled as OFFSET value in FIG. 25) between the FMA and the SLMA of sample point 100 for the sampled intervals over a period of time (e.g., from April 27 th to July 5 th ).
- FIG. 25 further shows a risk threshold.
- a risk threshold may be determined by the variation of FMA and SLMA values over a period of time as well as the difference in their respective values over a period of time.
- a risk threshold may also be specified as an absolute value.
- Monitoring system 222 may determine a risk of a health event based on a difference between the FMA and SLMA felling outside of the acceptable range, as shown in FIG. 25.
- the health event may be a cardiovascular event.
- the health event may be a stroke.
- the health event is a health care utilization event, such as a hospitalization.
- the health event may be sudden cardiac arrest (SCA).
- the health event may be a myocardial infarction (MI).
- an amount the determined difference (e.g., OFFSET) between the FMA and the SLMA fells outside the acceptable range may also indicate a risk of a health event.
- a number of consecutive sample intervals having the determined difference (e.g., OFFSET) occurring outside the acceptable range may indicate a risk of a health event.
- a number and/or percentage of sample intervals having the determined difference (e.g., OFFSET) occurring outside the acceptable range over a period of intervals may indicate a risk of a health event.
- the maximum or minimum difference (e.g., OFFSET) may indicate a risk of a health event.
- monitoring system 222 may calculate an absolute value of the determined difference (e.g., OFFSET) between the FMA and the SLMA and compare the absolute value of the determined difference to a risk threshold value.
- Monitoring system 222 may determine a risk of a health event based on the comparison of the absolute value of the determined difference (e.g., OFFSET) between the FMA and the SLMA to the risk threshold value.
- the absolute value of the determined difference (e.g., OFFSET) between the FMA and the SLMA being greater than the risk threshold may indicate a risk of health event, such as stroke.
- an amount the absolute value of the determined difference (e.g., OFFSET) between the FMA and the SLMA is greater than the risk threshold may also indicate a risk of a health event.
- a number of consecutive sample intervals having the absolute value of the determined difference (e.g., OFFSET) being greater than or equal to a risk threshold may indicate a risk of a health event.
- a number and/or percentage of sample intervals having the absolute value of the determined difference (e.g., OFFSET) being greater than or equal to a risk threshold over a period of intervals may indicate a risk of a health event.
- monitoring system 222 may flag one or more sample intervals when the comparison of the absolute value of the determined difference (e.g., OFFSET) between the FMA and the SLMA to the risk threshold value indicates a risk of a health event, such as discussed above. For example, monitoring system 222 may flag a sample interval, for example June 15 th , when the absolute value of the determined difference (e.g., OFFSET) between the FMA and the SLMA is greater than the risk threshold.
- the absolute value of the determined difference e.g., OFFSET
- monitoring system 222 may display a graph showing an average of sample point parameters for different period lengths over time.
- monitoring system 222 may also display an indication of what parameter points had the determined difference (e.g., OFFSET) between the FMA and the SLMA being greater than the risk threshold (e.g., OFFSET signal).
- FIGS. 26-29 show examples for the 10 days prior (e.g., case average) to the flagged interval date compared to a 10 -day average (e.g., control average) that was taken 60 days prior to the case average of flagged intervals being displayed as described above.
- monitoring system 222 may display such graphs to a clinician, service provider, or other treatment decision maker to determine a course of treatment in response to the displayed graphical data.
- monitoring system 222 may receive electrocardiogram (ECG) data of a patient, wherein the ECG data is generated by one or more sensing devices of the patient based on physiological signals of the patient sensed by the one or more sensing devices.
- ECG electrocardiogram
- monitoring system 222 obtain a plurality of heartbeat data from the ECG data.
- monitoring system 222 may determine a slow-moving metric based on the heartbeat data during a first period of time and determine a fast-moving metric based on the heartbeat data during a second period of time, the second period of time being less than the first period of time.
- the metric of the slow-moving metric and/or fast-moving metric may include one or more of an average, mode, mean, median, counts, and/or set of values of the heartbeat data over a period of time.
- monitoring system 222 may determine a slow-moving mode and a fast-moving mode of heartbeat data.
- monitoring system 222 may determine a risk level of a health event for the patient based on the slow-moving metric and the fast-moving metric.
- monitoring system 222 receives ECG data of patient 4 (600).
- the ECG data may be generated by one or more sensing devices of the patient based on physiological signals of the patient sensed by tire one or more sensing devices.
- Monitoring system 222 obtains a plurality of heartbeat intervals from the ECG data (602).
- Monitoring system 222 samples a plurality of points for each respective heartbeat interval of the plurality of intervals (604).
- each obtained heartbeat interval from the ECG data may be a single heartbeat interval or an average of a plurality of adjacent and/or neighboring heartbeats from the ECG data, such as, for example, an average of 10 adjacent or neighboring heartbeats.
- monitoring system 222 may normalize the plurality of sampled points for each respective heartbeat interval of the plurality of intervals.
- Monitoring system 222 determines a slow-moving average for each sample point parameter of respective heartbeat intervals for one period of time (606). Monitoring system 222 determines a fast-moving average for each sample point parameter of respective heartbeat intervals for a second period of time (608). As discussed above, the second period of time is less than the first period of time. Monitoring system 222 determines a difference between the slow-moving average and the fest-moving average for each sample point parameter (610). Monitoring system 222 determines a risk level of a health event for the patient based on the determined differences (612).
- monitoring system 222 may determine a comparison value for each sample point parameter by comparing an absolute value of the difference between the slow-moving average and the fast-moving average for each sample point parameter to a difference threshold and determine the risk level of the health event for the patient based on the comparison values for each sample point parameter. In some examples, monitoring system 222 may determine the risk level of the health event for the patient based on a number of consecutive parameter points having the respective comparison value above or equal to the comparison threshold. In some examples, monitoring system 222 may determine the risk level of the health event for the patient based on an amount of the comparison value.
- monitoring system 222 may generate an output to indicate the risk level of the health event.
- monitoring system 222 may generate suggested responses, such as treatment, changes in medication, suggestion to go to the hospital, to be output in response to determining the risk level of the health event.
- serious health events such as stoke, MI, or SCA, may be treated before the health event occurs, which may provide greater care for a patient and/or reduce healthcare costs.
- FIG. 31 illustrates an example methodology for rare event prediction using continuous monitoring data.
- diagnostic parameter data was partitioned to 70% training and 30% testing, under/oversampled, model fitted, and model tested for each of the 1000 bootstraps. This was repeated for seven different model structures.
- the bootstrapped mean area under the curve (AUG) and classification statistics were used to measure how well a methodology could predict the occurrence of ischemic stroke.
- the described techniques may be implemented in hardware, software, firmware, or any combination thereof. If implemented in software, the functions may be stored as one or more instructions or code on a computer-readable medium and executed by a hardware-based processing unit.
- Computer-readable media may include non-transitory computer-readable media, which corresponds to a tangible medium such as data storage media (e.g., RAM, ROM, EEPROM, flash memory, or any other medium that can be used to store desired program code in the form of instructions or data structures and that can be accessed by a computer).
- processors such as one or more digital signal processors (DSPs), general purpose microprocessors, application specific integrated circuits (ASICs), field programmable logic arrays (FPGAs), or other equivalent integrated or discrete logic circuitry.
- DSPs digital signal processors
- ASICs application specific integrated circuits
- FPGAs field programmable logic arrays
- processors may refer to any of the foregoing structure or any other physical structure suitable for implementation of the described techniques. Also, the techniques could be fully implemented in one or more circuits or logic elements.
- Example 1 A system includes a memory; and processing circuitry coupled to the memory and configured to: receive electrocardiogram (ECG) data of a patient, wherein the ECG data is generated by one or more sensing devices of the patient based on physiological signals of the patient sensed by the one or more sensing devices; obtain a plurality of heartbeat intervals from the ECG data; sample a plurality of points for each respective heartbeat interval of the plurality' of intervals; determine a slow-moving average for each sample point parameter of respective heartbeat intervals during a first period of time; determine a fest-moving average for each sample point parameter of respective heartbeat intervals during a second period of time, the second period of time being less than the first period of time; determine a difference between the slow-moving average and the fast-moving average for each sample point parameter; and determine a risk level of a health event for the patient based on the determined differences.
- ECG electrocardiogram
- Example 2 The system of example 1, wherein the processing circuitry is configured to obtain the plurality of heartbeat intervals at a respective particular time of day over a plurality' of days.
- Example 3 The system of any of examples 1 to 2, wherein the processing circuitry is further configured to normalize the plurality' of sampled points for each respective heartbeat interval of the plurality of intervals.
- Example 4 The system of any of examples 1 to 3, wherein the processing circuitry is further configured to: determine a comparison value for each sample point parameter by comparing an absolute value of the difference between the slow-moving average and the fast-moving average for each sample point parameter to a risk threshold; and determine the risk level of the health event for the patient based on the comparison values for each sample point parameter.
- Example 5 The system of any of examples 1 to 4, wherein the processing circuitry is further configured to determine the risk level of tire health event for the patient based on a number of consecutive parameter points having the respective comparison value above or equal to the comparison threshold.
- Example 6 The system of any of examples 1 to 4, wherein the processing circuitry is further configured to determine tire risk level of the health event for the patient based on an amount of the comparison value.
- Example 7 The system of any of examples 1 to 6, wherein the health event comprises stroke.
- Example 8 The system of any of examples 1 to 6, wherein the health event comprises a health care utilization event.
- Example 9 The system of any of examples 1 to 6, wherein the health event comprises sudden cardiac arrest.
- Example 10 The system of any of examples 1 to 9, wherein, to determine the risk level of the health event, the processing circuitry is configured to determine a probability of an occurrence of the health event.
- Example 11 The system of any of examples 1 to 10, wherein the risk level comprises a risk that the health event will occur within a predetermined time period.
- Example 12 The system of any of examples 1 to 11, wherein the processing circuitry is configured to determine whether the risk level of the health event satisfies a criterion.
- Example 13 A method includes receiving electrocardiogram (ECG) data of a patient, wherein the ECG data is generated by one or more sensing devices of the patient based on physiological signals of the patient sensed by the one or more sensing devices; obtaining a plurality of heartbeat intervals from the ECG data; sampling a plurality of points for each respective heartbeat interval of the plurality of intervals; determining a slow-moving average for each sample point parameter of respective heartbeat intervals during a first period of time; determining a fast-moving average for each sample point parameter of respective heartbeat intervals during a second period of time, the second period of time being less than the first period of time; determining a difference between the slow-moving average and the fast-moving average for each sample point parameter; and determining a risk level of a health event for the patient based on the determined differences.
- ECG electrocardiogram
- Example 14 The method of example 13, wherein the plurality of heartbeat intervals are obtained at a respective particular time of day over a plurality of days.
- Example 15 The method of any of examples 13 to 14, wherein the method further comprises normalizing the plurality of sampled points for each respective heartbeat interval of the plurality of intervals.
- Example 16 The method of any of examples 13 to 15, wherein the method further comprises: determining a comparison value for each sample point parameter by comparing an absolute value of the difference between the slow-moving average and the fast-moving average for each sample point parameter to a risk threshold; and determining the risk level of the health event for the patient based on the comparison values for each sample point parameter.
- Example 17 The method of any of examples 13 to 16, wherein the method further comprises determining the risk level of the health event for the patient based on a number of consecutive parameter points having the respective comparison value above or equal to the comparison threshold.
- Example 18 The method of any of examples 13 to 16, wherein the method further comprises determining the risk level of the health event for the patient based on an amount of the comparison value.
- Example 19 The method of any of examples 13 to 18, wherein the health event comprises stroke.
- Example 20 The method of any of examples 13 to 18, wherein the health event comprises a health care utilization event.
- Example 21 The method of any of examples 13 to 18, wherein the health event comprises sudden cardiac arrest.
- Example 22 The method of any of examples 13 to 21, wherein determining the risk level of the health event comprises determining a probability of an occurrence of the health event.
- Example 23 The method of any of examples 13 to 22, wherein the risk level comprises a risk that the health event will occur within a predetermined time period.
- Example 24 The method of any of examples 13 to 23, further comprising determining whether the risk level of the health event satisfies a criterion.
- Example 25 A method comprising any combination of the methods of examples
- Example 26 A computer-readable medium storing instructions that when executed by one or more processors cause the one or more processors to perform the method of any of examples 13-24.
- Example 27 A system includes a memory; and processing circuitry coupled to the memory and configured to: receive electrocardiogram (ECG) data of a patient, wherein the ECG data is generated by one or more sensing devices of the patient based on physiological signals of the patient sensed by the one or more sensing devices; obtain a plurality of heartbeat data from the ECG data; determine a slow-moving metric based on the heartbeat data during a first period of time; determine a fast-moving metric based on the heartbeat data dining a second period of time, the second period of time being less than the first period of time; and determine a risk level of a health event for the patient based on the slow-moving metric and the fast-moving metric.
- ECG electrocardiogram
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Physiology (AREA)
- Artificial Intelligence (AREA)
- Signal Processing (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Fuzzy Systems (AREA)
- Mathematical Physics (AREA)
- Evolutionary Computation (AREA)
- Computer Networks & Wireless Communication (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Multimedia (AREA)
- Dentistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263370761P | 2022-08-08 | 2022-08-08 | |
| PCT/US2023/028145 WO2024035530A1 (en) | 2022-08-08 | 2023-07-19 | Health event prediction using heartbeat intervals from electrocardiogram data |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP4568560A1 true EP4568560A1 (en) | 2025-06-18 |
Family
ID=87571618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP23754907.6A Pending EP4568560A1 (en) | 2022-08-08 | 2023-07-19 | Health event prediction using heartbeat intervals from electrocardiogram data |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP4568560A1 (en) |
| WO (1) | WO2024035530A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12257060B2 (en) | 2021-03-29 | 2025-03-25 | Pacesetter, Inc. | Methods and systems for predicting arrhythmia risk utilizing machine learning models |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7792572B1 (en) * | 2004-05-17 | 2010-09-07 | Pacesetter, Inc. | Ischemia detection using intra-cardiac signals |
| US7647104B1 (en) * | 2006-10-13 | 2010-01-12 | Pacesetter, Inc. | Ischemia detection using paced depolarization integral and intracardiac electrogram template comparison |
| WO2016183683A1 (en) * | 2015-05-20 | 2016-11-24 | University Health Network | Method and system for assessing qrs components and the risk of ventricular arrhythmias |
| US10058708B2 (en) * | 2015-06-30 | 2018-08-28 | Cardiac Pacemakers, Inc. | Heart failure event detection using minimum heart rate |
| US10893832B2 (en) * | 2016-01-13 | 2021-01-19 | Tufts Medical Center, Inc. | Predictive instrument to identify patients for use of pharmacological cardiac metabolic support |
-
2023
- 2023-07-19 EP EP23754907.6A patent/EP4568560A1/en active Pending
- 2023-07-19 WO PCT/US2023/028145 patent/WO2024035530A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024035530A1 (en) | 2024-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12308121B2 (en) | Machine learning based depolarization identification and arrhythmia localization visualization | |
| US12527966B2 (en) | Multi-tier prediction of cardiac tachyarrhythmia | |
| US12161487B2 (en) | Personalization of artificial intelligence models for analysis of cardiac rhythms | |
| CN113795891A (en) | Category-based review and reporting of seizure data | |
| US20240047072A1 (en) | Health event prediction | |
| WO2024035530A1 (en) | Health event prediction using heartbeat intervals from electrocardiogram data | |
| EP4622551A1 (en) | Health event prediction | |
| US20250268523A1 (en) | A system configured for chronic illness monitoring using information from multiple devices | |
| US20250118426A1 (en) | Techniques for improving efficiency of detection, communication, and secondary evaluation of health events | |
| CN116847781A (en) | Health event prediction | |
| US20260045366A1 (en) | Health event prediction and patient feedback system | |
| US20250040890A1 (en) | High-resolution diagnostic data system for patient recovery after heart failure intervention |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20250307 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20251219 |